aspirin 75mg dispersible tablets
wockhardt uk ltd - aspirin - dispersible tablet - 75mg
aspirin 75mg dispersible tablets
waymade healthcare plc - aspirin - dispersible tablet - 75mg
aspirin e-c low dose safety coated- aspirin tablet, coated
nucare pharmaceuticals,inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 81 mg - pain reliever - for the temporary relief of minor aches and pains or as recommended by your doctor. because of its delayed action, this product will not provide fast relief of headaches or other symptoms needing immediate relief. - ask your doctor about other uses for safety coated 81 mg aspirin
aspirin 75mg tablets
kent pharma (uk) ltd - aspirin - oral tablet - 75mg
aspirin 75mg tablets
medreich plc - aspirin - oral tablet - 75mg
aspirin and omeprazole delayed-release tab- aspirin and omeprazole tablet, film coated
innovida phamaceutique corporation - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - aspirin and omeprazole delayed-release tablets, a combination of aspirin and omeprazole, is indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers. the aspirin component of aspirin and omeprazole delayed-release tablets is indicated for: - reducing the combined risk of death and nonfatal stroke in patients who have had ischemic stroke or transient ischemia of the brain due to fibrin platelet emboli, - reducing the combined risk of death and nonfatal mi in patients with a previous mi or unstable angina pectoris, - reducing the combined risk of mi and sudden death in patients with chronic stable angina pectoris, - use in patients who have undergone revascularization procedures (coronary artery bypass graft [cabg] or percutaneous transluminal coronary angioplasty [ptca]) when there is a pre-existing condition for which aspirin is already indicated. the omeprazole component of aspirin and
aspirin and omeprazole delayed-release tab- aspirin and omeprazole tablet, film coated
innovida therapeutique corporation - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - aspirin and omeprazole delayed-release tabletsa, a combination of aspirin and omeprazole, is indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers. the aspirin component of aspirin and omeprazole delayed-release tabletsa is indicated for: - reducing the combined risk of death and nonfatal stroke in patients who have had ischemic stroke or transient ischemia of the brain due to fibrin platelet emboli, - reducing the combined risk of death and nonfatal mi in patients with a previous mi or unstable angina pectoris, - reducing the combined risk of mi and sudden death in patients with chronic stable angina pectoris, - use in patients who have undergone revascularization procedures (coronary artery bypass graft [cabg] or percutaneous transluminal coronary angioplasty [ptca]) when there is a pre-existing condition for which aspirin is already indicated. the omeprazole component of aspirin an
clopidogrel/aspirin sandoz 75/100 clopidogrel (as hydrogen sulfate) and aspirin 75 mg/100 mg uncoated tablet blister pack
sandoz pty ltd - aspirin,clopidogrel hydrogen sulfate -
aspirin 300mg gastro-resistant tablets
a a h pharmaceuticals ltd - aspirin - gastro-resistant tablet - 300mg
aspirin 300mg gastro-resistant tablets
the boots company plc - aspirin - gastro-resistant tablet - 300mg